Newstral
Christopher Raymond
- BMoney Is Moving Back Into Surging Biotech Fundsbarrons.com
- BGene-Therapy Firm Audentes Sells for Double Its Share Price. Analysts Expect More Deals.barrons.com
- BBiotech Stock Funds Continue to See Money Exitbarrons.com
- Police logs - Nov. 16, 2019The Day
- BBioMarin Stock Rises on Earnings Beatbarrons.com
- BBiogen Stock Is Soaring as Hope Returns for Alzheimer’s Drugbarrons.com
- BInvestors Pull Money From Biotech Funds for Seventh Weekbarrons.com
- BInvestors Are Still Pulling Money Out of Biotech Fundsbarrons.com
- BAbbVie Winning Over Skeptics As Analysts Warm To Allergan Dealbarrons.com
- BHealth-Care and Biotech Investors Are Pulling Billions of Dollars From Fundsbarrons.com
- BBuy AbbVie Stock Because You ‘Can’t Ignore’ How Cheap It Isbarrons.com
- BAn International Drug-Price Index Is Coming, Trump Official Saysbarrons.com
- BBioMarin Drops After Hours on Weak Earningsbarrons.com
- BAmgen's Earnings Weren't a Thrill, but Promising Cancer-Drug Results Are Lifting the Stockbarrons.com
- BAbbVie Discontinued a Drug Trial. Biogen Stock Is Falling.barrons.com
- BAlexion Investors Can't Catch a Break. Earnings Beat Forecasts, but the Stock Is Fallingbarrons.com
- BBiogen's Earnings Beat Forecasts, but 1 Key Drug Fell Shortbarrons.com
- BBiogen Stock Slips as Multiple Sclerosis Drug Has Fierce Competitionbarrons.com
- BAbbVie Is Gaining After Tuesday's Selloffbarrons.com
- BAbbVie Is Buying Allergan and Wall Street Is Doubtfulbarrons.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.